Megestrol acetate for cachexia-anorexia syndrome. A systematic review
Abstract In 1993, megestrol acetate (MA) was approved by the US Food and Drug Administration for the treatment of anorexia, cachexia, or unexplained weight loss in patients with acquired immunodeficiency syndrome. The mechanism by which MA increases appetite is unknown, and its effectiveness for ano...
में बचाया:
मुख्य लेखकों: | Vicente Ruiz‐García (लेखक), Eduardo López‐Briz (लेखक), Rafael Carbonell‐Sanchis (लेखक), Sylvia Bort‐Martí (लेखक), José Luis Gonzálvez‐Perales (लेखक) |
---|---|
स्वरूप: | पुस्तक |
प्रकाशित: |
Wiley,
2018-06-01T00:00:00Z.
|
विषय: | |
ऑनलाइन पहुंच: | Connect to this object online. |
टैग: |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|
समान संसाधन
-
Dose‐dependent effect of megestrol acetate supplementation in cancer patients with anorexia-cachexia syndrome: A meta‐analysis
द्वारा: Sepide Talebi, और अन्य
प्रकाशित: (2024) -
Adjuvant chemotherapy of megestrol acetate in advanced breast cancer: A meta-analysis
द्वारा: Yanping Shui, और अन्य
प्रकाशित: (2015) -
Characterizing the Drug-Release Enhancement Effect of Surfactants on Megestrol-Acetate-Loaded Granules
द्वारा: Gábor Katona, और अन्य
प्रकाशित: (2022) -
Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome
द्वारा: Naoki eFujitsuka, और अन्य
प्रकाशित: (2014) -
A Review of Olanzapine in the Treatment of Cancer Anorexia-Cachexia Syndrome
द्वारा: Ivy O. Poon, और अन्य
प्रकाशित: (2024)